Status:
COMPLETED
Evaluation of the Efficiency of the IsereADOM Home-care Service Package in the Prevention of Unplanned Hospitalizations of Patients With Cancer
Lead Sponsor:
Centre Leon Berard
Collaborating Sponsors:
Conseil general de l'Isere
Conditions:
Neoplasms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main objective of the project is to compare the effectiveness and efficiency of innovative care through the IsereADOM home-care service package versus standard care in the prevention of unplanned ...
Detailed Description
Specific management of cancer patients involves carrying out often heavy treatments (surgery, chemotherapy, radiotherapy, interventional radiology, etc.) during which close coaching is necessary. In s...
Eligibility Criteria
Inclusion
- age \> or = 18 years old at the time of signature of informed consent form
- patient with solid or hematologic tumor under treatment for cancer at the time of inclusion
- Patient managed in a medical emergency context in the 2 weeks prior to inclusion
- Patient living in Isère department (area of coverage of experiment)
- ECOG Performance index \< or = 3
- patient with a life expectancy of 6 months or more
- patient with social security system
- patient able to read, write and understand French
- patient with signed informed consent
Exclusion
- Patient included in clinical trial evaluating early stage therapeutic innovation with pharmacokinetic sampling
- Patients with follow-up in Hospitalization at Home at the end of the hospitalization for inclusion
- Patient without help "referent" in the entourage (spouse, family, friend ...)
- Patient residing in Elderly Accommodation (EHPAD) or in any other institution for dependent persons
- Patient who is homeless or living in a home that does not allow the installation of the necessary equipment
- Patient with severe cognitive impairment, defined by score at Mini Mental State Examination (MMSE)\< 23/30
- Patient unable to comply (or unwilling to comply) with follow-up of the study for the duration of participation
Key Trial Info
Start Date :
January 11 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 17 2019
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT03330730
Start Date
January 11 2018
End Date
June 17 2019
Last Update
December 13 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Léon Bérard
Lyon, Auvergne-Rhône-Alpes, France, 69008
2
CHU Grenoble Alpes
Grenoble, France
3
Institut Daniel Hollard
Grenoble, France